| May. 07, 2008 | Print This | Email This |
| |
|
|
|
An audio replay of the conference call will be available from 11:00 a.m. EDT on Wednesday, May 14, 2008, until Wednesday, May 21, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 14991737. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About Memory Pharmaceuticals
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura Perry,
LMP Investor Relations Inc., +1-646-719-1055
Web site: http://www.memorypharma.com/

